Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer. Among patients with platinum-sensitive peritoneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback